Filter
1592
Filtered Results: 1592
Text search:
human
pharmaceutical
products
Featured
Recommendations
149
New Publications
451
Language
Document type
No document type
822
Studies & Reports
317
Guidelines
236
Manuals
81
Strategic & Response Plan
78
Fact sheets
21
Training Material
18
Situation Updates
10
Resource Platforms
4
Brochures
2
Infographics
2
Online Courses
1
Countries / Regions
Kenya
66
Global
57
Ethiopia
55
India
51
Sierra Leone
35
Nigeria
35
South Africa
35
Western and Central Europe
32
Uganda
30
Liberia
30
Rwanda
27
Ghana
26
Nepal
25
Namibia
25
Tanzania
23
Zambia
23
Ukraine
19
Philippines
19
Malawi
18
Africa
17
Bangladesh
16
Latin America and the Carribbean
14
Lesotho
13
Eastern Europe
13
Indonesia
13
Zimbabwe
12
Myanmar / Burma
12
Cambodia
11
South–East Asia Region
11
Eswatini/ Swaziland
10
Syria
9
Botswana
9
West and Central Africa
8
Eastern Europe and Central Asia
8
East and Southern Africa
7
Burkina Faso
6
Guinea
6
Asia
6
Congo, Democratic Republic of
6
Haiti
5
South Sudan
5
Cameroon
4
Albania
4
Senegal
4
Venezuela
4
Pakistan
4
North Macedonia
3
Thailand
3
China
3
Fiji
3
Laos
3
Mozambique
3
USA
3
Jordan
3
Middle East and North Africa
3
Western Pacific Region
3
North America
3
Russia
3
Sudan
3
Tajikistan
2
Serbia
2
Benin
2
Kyrgyzstan
2
Afghanistan
2
Peru
2
Germany
2
Jamaica
2
Lebanon
2
Vietnam
2
Papua New Guinea
2
Brazil
2
Moldova
2
Egypt
2
Georgia
2
Central African Republic
2
Mali
2
Timor Leste/ East Timor
1
Australia
1
Kazakhstan
1
Iran
1
Niger
1
Uzbekistan
1
Bulgaria
1
Armenia
1
Ireland
1
Saudi Arabia
1
Gabon
1
Japan
1
Denmark
1
Maldives
1
United Kingdom
1
Southern Africa
1
Sri Lanka
1
Yemen
1
Angola
1
Libya
1
Bhutan
1
Iraq
1
Somalia
1
Ecuador
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
631
Clinical Guidelines
113
Public Health
85
Key Resources
82
Women & Child Health
42
Pharmacy & Technologies
23
Capacity Building
9
Annual Report MEDBOX
1
Toolboxes
AMR
176
Pharmacy
145
COVID-19
103
TB
76
HIV
70
Mental Health
69
NTDs
55
Rapid Response
54
Planetary Health
52
Global Health Education
38
Caregiver
29
Health Financing Toolbox
28
NCDs
28
Conflict
27
Ebola & Marburg
26
Specific Hazards
13
Refugee
10
Disability
10
Natural Hazards
8
Polio
8
Social Ethics
3
Zika
3
Cholera
1
The Ministry of Health together with its partners realizes that efficient and effective
delivery of clinical care is highly dependent on the availability of appropriately
upgraded environment, which is in well facilitated space. Such facilities and utilities
should always be properly designed, bu...
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u...
IN THE AMOUNT OF SDR 21.8 MILLION (US$30 MILLION EQUIVALENT) WITH AN ADDITIONAL GRANT FROM THE GLOBAL FINANCING FACILITY (GFF) IN THE AMOUNT OF US$ 10 MILLION TO THE DEMOCRATIC REPUBLIC OF CONGO FOR A HUMAN DEVELOPMENT SYSTEMS STRENGTHENING PROJECT
Rising levels of inflation, debt and macrofiscal tightening are putting expenditures on the social sectors including health under immense scrutiny. Already, there are worrying signs of reductions in social sector investments. However, even before the pandemic, evidence showed the significant returns...
Each year since 2007, G-FINDER has provided policy-makers, donors, researchers and industry with a comprehensive analysis of global investment into research and development of new products to
prevent, diagnose, control or cure neglected diseases in low- and middle-income countries, making it the go...
In 1998 the Swedish Veterinary Association decided to adopt a general policy for the use of antibiotics in animals. Since then specifi c policies for the use of antibiotics in dogs and cats have been adopted and in 2011 Guidelines for the use of Antibiotics in Production animals – Cattle and Pigs,...
Reports of antimicrobial-resistant (AMR) microorganisms are increasing globally, threatening to render existing treatments ineffective against many infectious diseases. In Africa, AMR has already been documented to be a problem for human immunodeficiency virus (HIV) and the pathogens that cause mala...
This third booklet of the World Drug Report 2022 has a dual focus: opioids and cannabis.
The first chapter of the booklet provides an overview of opioids as a group of substances and their patterns of non-medical use at the global level. It also reviews the latest trends in the global supply of opi...
This paper has been prepared to inform discussion at the conference “Beating the DRUM - Domestic Resource Use and Mobilization for accelerating progress towards SDG3,”. Many countries face critical shortfalls in domestic resource use and mobilization (DRUM) for health, threatening to push health...
The National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB), 2020-2025, presents
coordinated, strategic actions that the United States Government will take in the next five years to improve the health and wellbeing of all Americans by changing the course of antibiotic resistance.
T...
The Newborn Situational Analysis reports of 2009 and 2011, as well as the “Bottleneck analysis on neonatal health” of 2013, culminated in the Nigeria launch of “Call to action on Newborn health” at the first National Newborn Health Conference in 2014. This call to action provided the framewo...
Drugs and medical supplies are dispensed at the cutting edge level of the interface between the public health system and the people. Availability or lack of it brings either credit or discredit to the public health system. The primary reason for holding stocks of medicines and medical supplies in a ...
Noncommunicable diseases (NCDs) such as cancer, cardiovascular diseases, diabetes and chronic respiratory diseases and their risk factors are an increasing public health and development challenge in Kyrgyzstan. This report provides evidence through three analyses that NCDs reduce economic outp...
Scientists have known for more than half a century that patients could develop resistance to the drugs used to treat them. Alexander Fleming, who is credited with creating the first antibiotic, penicillin, in 1928, cautioned of the impending crisis while accepting his Nobel prize in 1945: “There ...
The purpose of the PAS III is to guide Pakistan’s overall national response for HIV and AIDS through 2020, through focused interventions with set targets, costs, roles and responsibilities. The successful implementation of PAS III involves multiple stakeholders to achieve priority outcomes outline...
Many features of the environment have been found to exert an important influence on cardiovascular disease (CVD) risk, progression, and severity. Changes in the environment due to migration to different geographic locations, modifications in lifestyle choices, and shifts in social policies and cultu...
The Ethiopian Hospital Services Transformation Guidelines (EHSTG) build on and expand the Ethiopian Hospital Reform Implementation Guidelines (EHRIG) and are consistent with the Health Sector Transformation Plan (HSTP). The EHSTG, which is consistent with the national focu...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug...
Training Manual
